1-3 of 3
Randy L. Davis, DrPH
Close
Sort by
Journal Articles

Ofatumumab Monotherapy for Treatment of Patients with Relapsed/Progressive Diffuse Large B-Cell Lymphoma: Results From a Multicenter Phase II Study

Bertrand Coiffier, MD, PhD, André Bosly, MD, Ka Lung Wu, MD, PhD, Gregor Verhoef, MD, PhD, Van Eygen Koen, MD, Giovanni Martinelli, MD, Gabriela Barca, MD, PhD, Andrew Davies, MRCP, PhD, Eve Gallop-Evans, PhD, Swaminathan Padmanabhan, MBBS, MS, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Randy L. Davis, DrPH, Nedjad Losic, MSC, Steen Lisby, MD, DMSC, John A. Radford, MD
Journal: Blood
Blood (2010) 116 (21): 3955.
https://doi.org/10.1182/blood.V116.21.3955.3955
Published: 2010
Journal Articles

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia

William G. Wierda, MD, PhD, Thomas J. Kipps, MD, PhD, Jiri Mayer, MD, PhD, Tadeusz Robak, MD, PhD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Richard R. Furman, MD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Stephan Stilgenbauer, M.D., Catherine D. Williams, FRCPath, Marek Trneny, MD, PhD, Guillaume Cartron, MD, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Swaminathan Padmanabhan, MBBS, MS, Geoffrey W. Chan, MD, Ira V. Gupta, MD, Michele M. Gorczyca, MS, Randy L. Davis, DrPH, Nedjad Losic, MSc, Steen Lisby, MD, DMSC, Anders Österborg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 921.
https://doi.org/10.1182/blood.V116.21.921.921
Published: 2010
Journal Articles

Ofatumumab (HuMax-CD20), a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with CLL Refractory to Both Fludarabine and Alemtuzumab or Bulky Fludarabine-Refractory Disease: Results from the Planned Interim Analysis of An International Pivotal Trial

Anders Osterborg, MD, PhD, Thomas J. Kipps, MD, PhD, Jiri Mayer, MD, Stephan Stilgenbauer, Dr.med, Catherine D Williams, MBBS, MRCP, FRCPath, Andrzej Hellmen, MD, PhD, Tadeusz Robak, MD, PhD, Richard R Furman, MD, Peter Hillmen, MBChB, PhD, Marek Trneny, MD, PhD, Martin J.S. Dyer, MA, DPhil, FRCP, Swaminathan Padmanabhan, MD, MBBS, Tomas Kozak, MD, PhD, Geoffrey Chan, MD, Randy L Davis, DrPH, Nedjad Losic, MSc, Charlotte A. Russell, MD, DMSC, Magdalena Piotrowska, MD, Joris Wilms, MSc., Pharm, William G. Wierda, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 328.
https://doi.org/10.1182/blood.V112.11.328.328
Published: 2008